Clinical Trial

Senescence in Myocardial Infarction

Study acronym: SMI
Terminated
View on ClinicalTrials.gov →
Why the trial stopped
Staffing challenges and subsequent withdrawal of funding.
Summary
The investigators of this study have found that after a heart attack, some heart cells rapidly age (become senescent) and release proteins that make the heart disease worse. The investigators of this study would like to check for these aged-cell proteins in participants who have coronary artery bypass graft (CABG) surgery after a recent heart attack or to treat more stable heart disease. The investigators will do this by taking blood samples and a sample of normally discarded heart tissue from each group of participants. This might help tell us who is at the highest risk of developing heart disease and how people recover from a heart attack.
Trial Details
NCT Number NCT07693712
Lead Sponsor South Tees Hospitals NHS Foundation Trust
Collaborators: Newcastle University
Conditions Cardiovascular Diseases, Coronary Artery Disease, Aging, Atherosclerosis, Myocardial Infarction, Inflammation, Heart Failure
Enrollment 22 participants
Start Date 2024-05-08
Primary Completion 2026-02-26 (estimated)
Study Completion 2026-02-26 (estimated)
Updated on ClinicalTrials.gov 2026-07-09